Role of integrin expression in the prediction of response to vedolizumab: A prospective real-life multicentre cohort study

Clin Transl Med. 2022 Apr;12(4):e769. doi: 10.1002/ctm2.769.

Cara De Galan^{1

2

3}, Gerard Bryan Gonzales^{1

2}, Sophie Van Welden^{1

2

3}, Simon Jan Tavernier⁴, Triana Lobaton^{1

5}, Wouter Van Moerkercke⁶, Beatrijs Strubbe⁷, Harald Peeters⁷, Elisabeth Macken⁸, Martine De Vos^{1

2}, Debby Laukens^{1

2

3}, Pieter Hindryckx^{1

5}

¹ Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
² Ghent Gut Inflammation Group (GGIG), Ghent University, Ghent, Belgium.
³ VIB Center for Inflammation Research, Ghent, Belgium.
⁴ Primary Immune Deficiency Research Lab, Centre for Primary Immunodeficiency Ghent, Jeffrey Model Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
⁵ Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium.
⁶ Department of Gastroenterology, AZ Groeninge, Kortrijk, Belgium.
⁷ Department of Gastroenterology, AZ Sint-Lucas Ghent, Ghent, Belgium.
⁸ Department of Gastroenterology, University Hospital Antwerp, Antwerp, Belgium.

No abstract available

Publication types